Bhanji Muna
SEC insider (Form 3/4/5 filer). CIK 0001846905. Director at VERACYTE, INC. (VCYT) and 3 other issuers. 14 reported Form 4/5 transactions since Sep 2024; latest on Oct 19, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Bhanji Muna has filed insider reports for
- VERACYTE, INC. (VCYT): Director
- ARDELYX, INC. (ARDX): Director
- Intellia Therapeutics, Inc. (NTLA): Director
- CYTOKINETICS INC (CYTK): Director
Bhanji Muna
CIK: 0001846905
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)6 (42.9%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)8 (57.1%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Oct 19, 2026VCYT
VERACYTE, INC.
SaleDirect1.9K shares at avg. $43.70$81K - Sep 1, 2026VCYT
VERACYTE, INC.
SaleDirect1.9K shares at avg. $42.97$80K - Jun 16, 2026ARDX
ARDELYX, INC.
AwardDirect26.5K shares- - Jun 11, 2026VCYT
VERACYTE, INC.
AwardDirect5.3K shares- - Jun 9, 2026NTLA
Intellia Therapeutics, Inc.
AwardDirect9.2K shares- - May 27, 2026CYTK
CYTOKINETICS INC
AwardDirect2.9K shares- - Jun 18, 2025ARDX
ARDELYX, INC.
AwardDirect41.6K shares- - Jun 18, 2025VCYT
VERACYTE, INC.
AwardDirect9.3K shares- - Jun 13, 2025VCYT
VERACYTE, INC.
SaleDirect4.6K shares at avg. $26.67$122K - Jun 11, 2025NTLA
Intellia Therapeutics, Inc.
AwardDirect8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 19, 2026 |  VCYT VERACYTE, INC. | Sale | 1,864 | $43.70 | $81,457 | Direct |
| Sep 1, 2026 | VCYT VERACYTE, INC. | Sale | 1,864 | $42.97 | $80,096 | Direct |
| Jun 16, 2026 |  ARDX ARDELYX, INC. | Award | 26,455 | - | $0 | Direct |
| Jun 11, 2026 | VCYT VERACYTE, INC. | Award | 5,272 | - | $0 | Direct |
| Jun 9, 2026 |  NTLA Intellia Therapeutics, Inc. | Award | 9,200 | - | $0 | Direct |
| May 27, 2026 |  CYTK CYTOKINETICS INC | Award | 2,851 | - | $0 | Direct |
| Jun 18, 2025 | ARDX ARDELYX, INC. | Award | 41,551 | - | - | Direct |
| Jun 18, 2025 | VCYT VERACYTE, INC. | Award | 9,321 | - | - | Direct |
| Jun 13, 2025 | VCYT VERACYTE, INC. | Sale | 4,589 | $26.67 | $122,367 | Direct |
| Jun 11, 2025 | NTLA Intellia Therapeutics, Inc. | Award | 8,000 | - | - | Direct |
1-10 of 14 transactions